The study, led by Patrick Singleton, PhD, adds evidence that mu opioid receptors in cancer cells influence cancer progression and spread. These receptors could become a therapeutic target for cancer treatment.
Dr. Singleton’s findings also could influence surgical anesthesia used during cancer surgery.
More Articles on Anesthesia:
Attention Anesthesiologists: CMS Guidelines on Signatures and Check Boxes
Anesthesia Machine Sales Expected to Pick Up in 2014
Heritage Valley Names Dr. Brett Anderson Chair of Anesthesiology
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.